CA3099479A1 — Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof
Assigned to Ayala Pharmaceuticals Inc · Expires 2019-11-14 · 7y expired
What this patent protects
The present invention provides compositions comprising bisfluoroalky1-1,4-benzodiazepinone compounds, including compounds of Formula (I) or prodrugs thereof; in combination with an additional cancer therapeutic agent, and methods of use thereof for treating diseases and disorders…
USPTO Abstract
The present invention provides compositions comprising bisfluoroalky1-1,4-benzodiazepinone compounds, including compounds of Formula (I) or prodrugs thereof; in combination with an additional cancer therapeutic agent, and methods of use thereof for treating diseases and disorders such as cancer.
Drugs covered by this patent
- Verzenio (abemaciclib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.